| [1] |
Hackett P H, Roach R C. High-altitude illness [J]. N Engl J Med, 2001, 345: 107-114.
|
| [2] |
Luks A M, Swenson E R. Medication and dosage considerations in the prophylaxis and treatment of high-altitude illness [J]. Chest, 2008, 133(3): 744-755.
|
| [3] |
Bärtsch P, Swenson E R. Clinical practice: acute high-altitude illnesses[J]. N Engl J Med, 2013, 368(24): 2294-2302.
|
| [4] |
Johnson N J, Luks A M. High-Altitude Medicine [J]. Med Clin North Am, 2016, 100(2): 357-369.
|
| [5] |
Luks A M, McIntosh S E, Grissom C K, et al. Wilderness Medical Society practice guidelines for the prevention and treatment of acute altitude illness: 2014 update [J]. Wilderness Environ Med, 2014, 25(4 Suppl): S4-S14.
|
| [6] |
Hackett P H, Rennie D, Levine H D. The incidence, importance, and prophylaxis of acute mountain sickness [J]. Lancet, 1976, 2(7996): 1149-1155.
|
| [7] |
Bloch K E, Turk A J, Maggiorini M, et al. Effect of ascent protocol on acute mountain sickness and success at Muztagh Ata, 7546 m[J]. High Alt Med Biol, 2009, 10(1): 25-32.
|
| [8] |
Forwand S A, Landowne M, Follansbee J N, et al. Effect of acetazolamide on acute mountain sickness [J]. N Engl J Med, 1968, 279(16): 839-845.
|
| [9] |
Dumont L, Mardirosoff C, Tramèr M R. Efficacy and harm of pharmacological prevention of acute mountain sickness: quantitative systematic review [J]. BMJ, 2000, 321(7256): 267-272.
|
| [10] |
Gomolin I H, Chapron D J. Elucidating the relationship between acetazolamide plasma protein binding and renal clearance using an albumin infusion [J]. J Clin Pharmacol, 1992, 32(11): 1028-1032.
|
| [11] |
Ellsworth A J, Larson E B, Strickland D. A randomized trial of dexamethasone and acetazolamide for acute mountain sickness prophylaxis [J]. Am J Med, 1987, 83(6): 1024-1030.
|
| [12] |
Ellsworth A J, Meyer E F, Larson E B. Acetazolamide or dexamethasone use versus placebo to prevent acute mountain sickness on Mount Rainier [J]. West J Med, 1991, 154(3): 289-293.
|
| [13] |
Bernhard W N, Schalick L M, Delaney P A, et al. Acetazolamide plus low-dose dexamethasone is better than acetazolamide alone to ameliorate symptoms of acute mountain sickness [J]. Aviat Space Environ Med, 1998, 69(9): 883-886.
|
| [14] |
Lipman G S, Kanaan N C, Holck P S, et al. Ibuprofen prevents altitude illness: a randomized controlled trial for prevention of altitude illness with nonsteroidal anti-inflammatories [J]. Ann Emerg Med, 2012, 59(6): 484-490.
|
| [15] |
Burtscher M, Likar R, Nachbauer W, et al. Aspirin for prophylaxis against headache at high altitudes: randomised, double blind, placebo controlled trial[J]. BMJ, 1998, 316(7137): 1057-1058.
|
| [16] |
Azietaku J T, Ma H, Yu X A, et al. A review of the ethnopharmacology, phytochemistry and pharmacology of Notopterygium incisum [J]. J Ethnopharmacol, 2017, 202(16):241-255.
|
| [17] |
Grissom C K, Roach R C, Sarnquist F H, et al. Acetazolamide in the treatment of acute mountain sickness: clinical efficacy and effect on gas exchange [J]. Ann Intern Med, 1992, 116(6): 461-465.
|
| [18] |
Ferrazzini G, Maggiorini M, Kriemler S, et al. Successful treatment of acute mountain sickness with dexamethasone[J]. Br Med J (Clin Res Ed), 1987, 294(6584): 1380-1382.
|
| [19] |
Levine B D, Yoshimura K, Kobayashi T, et al. Dexamethasone in the treatment of acute mountain sickness [J]. N Engl J Med, 1989, 321(25): 1707-1713.
|
| [20] |
Hackett P H, Roach R C, Wood R A, et al. Dexamethasone for prevention and treatment of acute mountain sickness[J]. Aviat Space Environ Med, 1988, 59(10): 950-954.
|
| [21] |
Keller H R, Maggiorini M, Bärtsch P, et al. Simulated descent v dexamethasone in treatment of acute mountain sickness: a randomised trial [J]. BMJ, 1995, 310(6989): 1232-1235.
|
| [22] |
Broome J R, Stoneham M D, Beeley J M, et al. High altitude headache: treatment with ibuprofen [J]. Aviat Space Environ Med, 1994, 65(1): 19-20.
|
| [23] |
Burtscher M, Likar R, Nachbauer W, et al. Ibuprofen versus sumatriptan for high-altitude headache [J]. Lancet, 1995, 346(8969): 254-255.
|
| [24] |
Beaumont M, Goldenberg F, Lejeune D, et al. Effect of zolpidem on sleep and ventilatory patterns at simulated altitude of 4,000 meters[J]. Am J Respir Crit Care Med, 1996, 153: 1864-1869.
|
| [25] |
Swenson E R, Maggiorini M, Mongovin S, et al. Pathogenesis of high-altitude pulmonary edema: inflammation is not an etiologic factor [J]. JAMA, 2002, 287(17): 2228-2235.
|
| [26] |
Bärtsch P, Mairbäurl H, Maggiorini M, et al. Physiological aspects of high-altitude pulmonary edema [J]. J Appl Physiol, 2005, 98(3): 1101-1110.
|
| [27] |
Luks A M. Can patients with pulmonary hypertension travel to high altitude?[J]. High Alt Med Biol, 2009, 10(3): 215-219.
|
| [28] |
Bärtsch P, Maggiorini M, Ritter M, et al. Prevention of high-altitude pulmonary edema by nifedipine [J]. N Engl J Med, 1991, 325(18): 1284-1289.
|
| [29] |
Deshwal R, Iqbal M, Basnet S. Nifedipine for the treatment of high altitude pulmonary edema [J]. Wilderness Environ Med, 2012, 23(1): 7-10.
|
| [30] |
Oelz O, Maggiorini M, Ritter M, et al. Nifedipine for high altitude pulmonary oedema [J]. Lancet, 1989, 2(8674): 1241-1244.
|
| [31] |
Maggiorini M, Brunner-La Rocca H P, Peth S, et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial [J]. Ann Intern Med, 2006, 145(7): 497-506.
|
| [32] |
Fagenholz P J, Gutman J A, Murray A F, et al. Treatment of high altitude pulmonary edema at 4240 m in Nepal [J]. High Alt Med Biol, 2007, 8(2): 139-146.
|
| [33] |
Das B B, Wolfe R R, Chan K C, et al. High-altitude pulmonary edema in children with underlying cardiopulmonary disorders and pulmonary hypertension living at altitude[J]. Arch Pediatr Adolesc Med, 2004, 158(12): 1170-1176.
|
| [34] |
Sartori C, Allemann Y, Duplain H, et al. Salmeterol for the prevention of high-altitude pulmonary edema[J]. N Engl J Med, 2002, 346(21): 1631-1636.
|
| [35] |
HÖhne C, Krebs M O, Seiferheld M, et al. Acetazolamide prevents hypoxic pulmonary vasoconstriction in conscious dogs [J]. J Appl Physiol (1985), 2004, 97(2): 515-521.
|
| [36] |
Teppema L J, Balanos G M, Steinback C D, et al. Effects of acetazolamide on ventilatory, cerebrovascular, and pulmonary vascular responses to hypoxia[J]. Am J Respir Crit Care Med, 2007, 175(3): 277-281.
|
| [37] |
Luks A M. Do we have a “best practice” for treating high altitude pulmonary edema?[J]. High Alt Med Biol, 2008, 9(2): 111-114.
|
| [38] |
Oelz O, Noti C, Ritter M, et al. Nifedipine for high altitude pulmonary oedema [J]. Lancet, 1991, 337(8740): 556.
|
| [39] |
Hackett P H, Roach R C, Hartig G S, et al. The effect of vasodilators on pulmonary hemodynamics in high altitude pulmonary edema: a comparison [J]. Int J Sports Med, 1992, 13(Suppl 1): S68-S71.
|
|
|
2017, Vol. 28 
